ReachMD

Episodes 1-15 of 15

• • 

    

    Javed Butler, MD, MPH, MBA

    Peer

  2

  

  RestartResume

  Mr. Jackson ist neu in der Stadt: Das Bewältigen von Herausforderungen bei der Optimierung der RAASi-Therapie

  Mr. Jackson ist neu in der Stadt: Das Bewältigen von Herausforderungen bei der Optimierung der RAASi-Therapie

  0.25 credits

• • 

    

    Gregory Lewis, MD

    Peer

  • 

    

    Michael Böhm, MD, FESC

    Peer

  • 

    

    Josep Comin-Colet, MD, PhD

    Peer

  11

  

  RestartResume

  Clinical Implications of Managing Iron Deficiency from AFFIRM-AHF

  Clinical Implications of Managing Iron Deficiency from AFFIRM-AHF

  0.25 credits

• • 

    

    Javed Butler, MD, MPH, MBA

    Peer

  • 

    

    Piotr Ponikowski, MD, PHD, FESC, FHFA

    Peer

  • 

    

    Gerasimos Filippatos, MD, FESC, FHFA

    Peer

  6

  

  RestartResume

  AHA 2020: Neue Erkenntnisse zu Eisenmangel und Herzinsuffizienz

  AHA 2020: Neue Erkenntnisse zu Eisenmangel und Herzinsuffizienz

  0.25 credits

• • 

    

    Javed Butler, MD, MPH, MBA

    Peer

  • 

    

    Piotr Ponikowski, MD, PHD, FESC, FHFA

    Peer

  • 

    

    Gerasimos Filippatos, MD, FESC, FHFA

    Peer

  12

  

  RestartResume

  AHA 2020: New Insights on Iron Deficiency and Heart Failure

  AHA 2020: New Insights on Iron Deficiency and Heart Failure

  0.25 credits

• • 

    

    Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP

    Peer

  • 

    

    Peter Pickkers, MD, PhD

    Peer

  • 

    

    Alexander Zarbock, MD

    Peer

  10

  

  RestartResume

  Cases in Acute Kidney Injury: Applications for Clinical Practice

  Cases in Acute Kidney Injury: Applications for Clinical Practice

  0.25 credits

• • 

    

    Javed Butler, MD, MPH, MBA

    Peer

  • 

    

    Peter van der Meer, MD, PhD

    Peer

  10

  

  RestartResume

  Common Misconceptions About Iron Deficiency in Heart Failure and What to Do About It

  Common Misconceptions About Iron Deficiency in Heart Failure and What to Do About It

  0.25 credits

• • 

    

    George Bakris, MD

    Peer

  • 

    

    Matthew R. Weir, MD

    Peer

  • 

    

    Faiez Zannad, MD, PhD

    Peer

  10

  

  RestartResume

  Potassium Management Made Easy

  Potassium Management Made Easy

  0.25 credits

• • 

    

    Austin G. Stack, MBBCh, MD, MSc, FASN, FRCPI

    Peer

  • 

    

    Mikhail Kosiborod, MD

    Peer

  20

  

  RestartResume

  Management of Heart Failure: Time to Consider New Options?

  Management of Heart Failure: Time to Consider New Options?

  0.25 credits

• • 

    

    Javed Butler, MD, MPH, MBA

    Peer

  7

  

  RestartResume

  Mr. Jackson Moves to Town: Overcoming Challenges to Optimizing RAASi Therapy

  Mr. Jackson Moves to Town: Overcoming Challenges to Optimizing RAASi Therapy

  0.25 credits

• • 

    

    Ewa A. Jankowska, MD, PhD, FESC

    Peer

  • 

    

    Stefan D. Anker, MD, PhD

    Peer

  16

  

  RestartResume

  Beyond Anemia: Understanding the Significance and Treatment of Iron Deficiency

  Beyond Anemia: Understanding the Significance and Treatment of Iron Deficiency

  0.25 credits

• • 

    

    Robert J. Mentz, MD

    Peer

  • 

    

    Piotr Ponikowski, MD, PHD, FESC, FHFA

    Peer

  15

  

  RestartResume

  Don’t Be Fooled: It’s Not Just Anemia, It’s Iron Deficiency

  Don’t Be Fooled: It’s Not Just Anemia, It’s Iron Deficiency

  0.25 credits

• • 

    

    Ileana L. Piña, MD, MPH, FAHA, FACC

    Peer

  • 

    

    Javed Butler, MD, MPH, MBA

    Peer

  • 

    

    Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA

    Peer

  14

  

  RestartResume

  Examining Heart Failure Management: How Can We Do Better?

  Examining Heart Failure Management: How Can We Do Better?

  0.25 credits

• • 

    

    Ileana L. Piña, MD, MPH, FAHA, FACC

    Peer

  • 

    

    Patrick Rossignol, MD, PhD

    Peer

  14

  

  RestartResume

  Potassium Binders in Heart Failure: Who, When, and How

  Potassium Binders in Heart Failure: Who, When, and How

  0.25 credits

• • 

    

    Jay L. Koyner, MD

    Peer

  • 

    

    Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP

    Peer

  • 

    

    John A. Kellum, MD, MCCM

    Peer

  13

  

  RestartResume

  Early Recognition of Acute Kidney Injury: What’s the Role of Biomarkers?

  Early Recognition of Acute Kidney Injury: What’s the Role of Biomarkers?

  0.25 credits

• • 

    

    Ravindra L. Mehta, MD

    Peer

  • 

    

    Rajit K. Basu, MD, MS, FCCM

    Peer

  15

  

  RestartResume

  Acute Kidney Injury: Finding a Pathway to Improved Patient Outcomes

  Acute Kidney Injury: Finding a Pathway to Improved Patient Outcomes

  0.25 credits